Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 12th Nov 2013 09:20

Accesso: Canaccord Genuity raises target price from 680p to 770p and keeps a buy recommendation.Andor Technology: FinnCap places both its target price (prev.: 390p) and its hold recommendation under review.Babcock International: Jefferies increases target price from 1250p to 1600p retaining a buy recommendation. Investec places its target price (prev.: 1175p) under review, while keeping its add rating.Balfour Beatty: UBS raises target price from 220p to 245p, while downgrading from neutral to sell.British Sky Broadcasting: Alphavalue shifts target price from 1055.2p to 1056.7p and upgrades from add to buy. Credit Suisse reduces target price from 810p to 700p downgrading to underperform.BTG: Investec places its target price (prev.: 472p) under review, while its buy recommendation is kept.Catlin Group: Canaccord Genuity moves target price from 540p to 550p and maintains a buy recommendation.Central Asia Materials: FinnCap initiates with a target price of 222p and a buy recommendation. Canaccord Genuity takes target price from 210p to 245p and stays with its buy recommendation.Chesnara: Canaccord Genuity moves target price from 290p to 300p, while downgrading from buy to hold.Cobham: Deutsche Bank lowers target price from 275p to 270p and maintains a hold recommendation. JP Morgan cuts target price from 310p to 270p reiterating a neutral rating. UBS lowers target price from 305p to 290p leaving its buy recommendation unchanged.Coca-Cola HBC: Goldman Sachs reduces target price from 2100p to 2000p and retains a neutral rating.Craneware: Investec raises target price from 365p to 530p and maintains a buy recommendation.Cropper (James): Westhouse Securities increases target price from 350p to 450p, while downgrading to add.F&C Asset Management: Barclays initiates with a target price of 90p and an underweight rating.GlaxoSmithKline: Panmure Gordon reduces target price from 1850p to 1750p and downgrades from buy to hold.Halfords Group: Deutsche Bank raises target price from 330p to 410p, but still recommends selling.Hunting: FinnCap cuts target price from 900p to 840p, while its hold recommendation is kept.Inmarsat: Alphavalue shifts target price from 729.7p to 732.6p upgrading from reduce to add.Ithaca Energy: Liberum Capital moves target price from 210p to 207p, while staying with its buy recommendation.Lonmin: Deutsche Bank increases target price from 315p to 390p and stays with its hold recommendation. Citi ups target price from 420p to 453p and reiterates a buy recommendation. HSBC raises target price from 485p to 512p leaving its overweight rating unaltered. JP Morgan takes target price from 400p to 430p and keeps an overweight rating.Morgan Advanced Materials: Jefferies lowers target price from 345p to 340p staying with its buy recommendation. JP Morgan moves target price from 335p to 330p, while leaving its overweight rating unchanged. Investec reduces target price from 410p to 390p, while its buy recommendation remains unchanged.Rentokil: Jefferies raises target price from 104p to 116p and keeps a hold recommendation.Rightmove: Panmure Gordon takes target price from 3000p to 3130p maintaining a buy recommendation.Royal Bank of Scotland: Nomura ups target price from 270p to 285p maintaining a reduce rating.RSA Insurance Group: Deutsche Bank shifts target price from 117p to 115p and retains a hold recommendation. Nomura lowers target price fromk 120p to 113p reiterating a neutral rating. JP Morgan cuts target price from 140p to 126p and downgrades to neutral.Shire: Societe Generale increases target price from 3270p to 3615p reiterating a buy recommendation.Smith (WH): Deutsche Bank raises target price from 960p to 1075p maintaining a buy recommendation. UBS increases target price from 750p to 1000p.Speedy Hire: Panmure Gordon shifts target price from 73.6p to 75p and stays with its hold recommendation.Synergy Health: Investec moves target price from 1140p to 1165p and reiterates a buy recommendation.Trifast: N+1 Singer ups target price from 68p to 89p and leaves its buy recommendation unchanged. FinnCap takes target price from 66p to 91p retaining a buy recommendation. Westhouse Securities places both its target price (prev.: 80p) and its buy recommendation under review.Vodafone Group: Espirito Santo ups target price from 215p to 230p and retains a neutral rating.Workspace Group: Liberum Capital takes target price from 546p to 584p and maintains a buy recommendation. Investec ups target price from 500p to 560p retaining a buy recommendation.
More News
Today 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
Today 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
Today 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.